PIK3CA and ductal breast carcinoma in situ: Dr. Satoi Nagasawa from the University of Tokyo performed ST analysis on DCIS, revealing that mutations in GATA Binding Protein 3 (GATA3) and Phosphoinositide-3-Kinase, Catalytic, Alpha Polypeptide (PIK3CA) are the most prevalent within this cohort.